Promoting COVID-19 vaccine acceptance: recommendations from the Lancet Commission on Vaccine Refusal, Acceptance, and Demand in the USA
Omer, Saad B, Benjamin, Regina M, Brewer, Noel T, Buttenheim, Alison M, Callaghan, Timothy, Caplan, Arthur, Carpiano, Richard M, Clinton, Chelsea, DiResta, Renee, Elharake, Jad A, Flowers, Lisa C, Galvani, Alison P, Lakshmanan, Rekha, Maldonado, Yvonne A, McFadden, SarahAnn M, Mello, Michelle M, Opel, Douglas J, Reiss, Dorit R, Salmon, Daniel A, Schwartz, Jason L, Sharfstein, Joshua M, Hotez, Peter J
Published in The Lancet (British edition) (11.12.2021)
Published in The Lancet (British edition) (11.12.2021)
Get full text
Journal Article
Human Intestinal Parasite Burden and Poor Sanitation in Rural Alabama
McKenna, Megan L, McAtee, Shannon, Bryan, Patricia E, Jeun, Rebecca, Ward, Tabitha, Kraus, Jacob, Bottazzi, Maria E, Hotez, Peter J, Flowers, Catherine C, Mejia, Rojelio
Published in The American journal of tropical medicine and hygiene (08.11.2017)
Published in The American journal of tropical medicine and hygiene (08.11.2017)
Get full text
Journal Article
Peripheral T-cell lymphomas in a large US multicenter cohort: prognostication in the modern era including impact of frontline therapy
Abramson, J.S., Feldman, T., Kroll-Desrosiers, A.R., Muffly, L.S., Winer, E., Flowers, C.R., Lansigan, F., Nabhan, C., Nastoupil, L.J., Nath, R., Goy, A., Castillo, J.J., Jagadeesh, D., Woda, B., Rosen, S.T., Smith, S.M., Evens, A.M.
Published in Annals of oncology (01.11.2014)
Published in Annals of oncology (01.11.2014)
Get full text
Journal Article
Progression-free survival at 24 months (PFS24) and subsequent outcome for patients with diffuse large B-cell lymphoma (DLBCL) enrolled on randomized clinical trials
Maurer, M.J., Habermann, T.M., Shi, Q., Schmitz, N., Cunningham, D., Pfreundschuh, M., Seymour, J.F., Jaeger, U., Haioun, C., Tilly, H., Ghesquieres, H., Merli, F., Ziepert, M., Herbrecht, R., Flament, J., Fu, T., Flowers, C.R., Coiffier, B.
Published in Annals of oncology (01.08.2018)
Published in Annals of oncology (01.08.2018)
Get full text
Journal Article
Venetoclax, bendamustine, and rituximab in patients with relapsed or refractory NHL: a phase Ib dose-finding study
de Vos, S., Swinnen, L.J., Wang, D., Reid, E., Fowler, N., Cordero, J., Dunbar, M., Enschede, S.H., Nolan, C., Petrich, A.M., Ross, J.A., Salem, A.H., Verdugo, M., Agarwal, S., Zhou, L., Kozloff, M., Nastoupil, L.J., Flowers, C.R.
Published in Annals of oncology (01.09.2018)
Published in Annals of oncology (01.09.2018)
Get full text
Journal Article
Clinical use of PI3K inhibitors in B-cell lymphoid malignancies: today and tomorrow
Greenwell, I B, Flowers, C R, Blum, K A, Cohen, J B
Published in Expert review of anticancer therapy (04.03.2017)
Published in Expert review of anticancer therapy (04.03.2017)
Get more information
Journal Article
Clinically significant liver injury in patients treated with natalizumab
BEZABEH, S., FLOWERS, C. M., KORTEPETER, C., AVIGAN, M.
Published in Alimentary pharmacology & therapeutics (01.05.2010)
Published in Alimentary pharmacology & therapeutics (01.05.2010)
Get full text
Journal Article
Examination of the follicular lymphoma international prognostic index (FLIPI) in the National LymphoCare study (NLCS): a prospective US patient cohort treated predominantly in community practices
Nooka, A.K., Nabhan, C., Zhou, X., Taylor, M.D., Byrtek, M., Miller, T.P., Friedberg, J.W., Zelenetz, A.D., Link, B.K., Cerhan, J.R., Dillon, H., Sinha, R., Shenoy, P.J., Levy, D., Dawson, K., Hirata, J.H., Flowers, C.R.
Published in Annals of oncology (01.02.2013)
Published in Annals of oncology (01.02.2013)
Get full text
Journal Article
Unmet needs in the first-line treatment of follicular lymphoma
Casulo, C., Nastoupil, L., Fowler, N.H., Friedberg, J.W., Flowers, C.R.
Published in Annals of oncology (01.09.2017)
Published in Annals of oncology (01.09.2017)
Get full text
Journal Article
Autologous stem cell transplantation for untreated transformed indolent B‐cell lymphoma in first remission: an international, multi‐centre propensity‐score‐matched study
Chin, C. K., Lim, K. J., Lewis, K., Jain, P., Qing, Y., Feng, L., Cheah, C. Y., Seymour, J. F., Ritchie, D., Burbury, K., Tam, C. S., Fowler, N. H., Fayad, L. E., Westin, J. R., Neelapu, S. S., Hagemeister, F. B., Samaniego, F., Flowers, C. R., Nastoupil, L. J., Dickinson, M. J.
Published in British journal of haematology (01.12.2020)
Published in British journal of haematology (01.12.2020)
Get full text
Journal Article
Incentives for COVID-19 vaccination
Brewer, Noel T., Buttenheim, Alison M., Clinton, Chelsea V., Mello, Michelle M., Benjamin, Regina M., Callaghan, Timothy, Caplan, Arthur, Carpiano, Richard M., DiResta, Renee, Elharake, Jad A., Flowers, Lisa C., Galvani, Alison P., Hotez, Peter J., Lakshmanan, Rekha, Maldonado, Yvonne A., Omer, Saad B., Salmon, Daniel A., Schwartz, Jason L., Sharfstein, Joshua M., Opel, Douglas J.
Published in Lancet Regional Health - Americas (Online) (01.04.2022)
Published in Lancet Regional Health - Americas (Online) (01.04.2022)
Get full text
Journal Article
Molecular impact of selective NFKB1 and NFKB2 signaling on DLBCL phenotype
Guo, X, Koff, J L, Moffitt, A B, Cinar, M, Ramachandiran, S, Chen, Z, Switchenko, J M, Mosunjac, M, Neill, S G, Mann, K P, Bagirov, M, Du, Y, Natkunam, Y, Khoury, H J, Rossi, M R, Harris, W, Flowers, C R, Lossos, I S, Boise, L H, Dave, S S, Kowalski, J, Bernal-Mizrachi, L
Published in Oncogene (20.07.2017)
Published in Oncogene (20.07.2017)
Get full text
Journal Article
SMART STOP: A PHASE II CLINICAL TRIAL OF LENALIDOMIDE, TAFASITAMAB, RITUXIMAB, AND ACALABRUTINIB ALONE AND WITH RESPONSE ADAPTED CHEMOTHERAPY IN PATIENTS WITH NEWLY DIAGNOSED DLBCL
Westin, J., Strati, P., Chihara, D., Pulsifer, B., Tom, J., Davis, R. E., Lee, H. J., Nair, R., Rodriguez, A., Hagemeister, F., Flowers, C., Nastoupil, L., Feng, L., Green, M., Fayad, L., Iyer, S., Ahmed, S., Steiner, R.
Published in Hematological oncology (01.06.2023)
Published in Hematological oncology (01.06.2023)
Get full text
Journal Article
Brentuximab Vedotin‐Nivolumab alone and then with Rituximab‐Cyclophosphamide‐Doxorubicin‐Prednisone as Frontline Therapy of Primary Mediastinal Large B‐cell Lymphoma
Steiner, R. E., Strati, P., Flowers, C. R., Neelapu, S. S., Green, M., Nastoupil, L. J., Hagemeister, F. B., Feng, L., Ahmed, S., Nair, R., Fayad, L., Lee, H. J., Rodriguez, M. A., Westin, J. R.
Published in Hematological oncology (01.06.2023)
Published in Hematological oncology (01.06.2023)
Get full text
Journal Article
CIRCULATING TUMOR DNA (CTDNA) STATUS AND CLINICAL OUTCOMES IN PATIENTS (PTS) WITH PREVIOUSLY UNTREATED DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL) IN THE POLARIX STUDY
Herrera, A. F., Tracy, S., Sehn, L. H., Jardin, F., Lenz, G., Trněný, M., Salles, G., Flowers, C. R., Tilly, H., Sharman, J. P., Friedberg, J. W., Balasubramanian, S., Raghavan, V., Hirata, J., Lee, C., Jiang, Y., Morschhauser, F.
Published in Hematological oncology (01.06.2023)
Published in Hematological oncology (01.06.2023)
Get full text
Journal Article
Disease characteristics, treatment patterns, and outcomes of follicular lymphoma in patients 40 years of age and younger: an analysis from the National Lymphocare Study
Casulo, C., Day, B., Dawson, K.L., Zhou, X., Flowers, C.R., Farber, C.M., Hainsworth, J.D., Cerhan, J.R., Link, B.K., Zelenetz, A.D., Friedberg, J.W.
Published in Annals of oncology (01.11.2015)
Published in Annals of oncology (01.11.2015)
Get full text
Journal Article